Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
Blood|October 27, 2005
Immunotherapy of high-risk acute leukemia with a recipient (autologous) vaccine expressing transgenic human CD40L and IL-2 after chemotherapy and allogeneic stem cell transplantationRaphaël F Rousseau, Ettore Biagi, Aurélie Dutour, et al.
Haematologica|July 4, 2007
Repeated infusions of donor-derived cytokine-induced killer cells in patients relapsing after allogeneic stem cell transplantation: a phase I studyMartino Introna, Gianmaria Borleri, Elena Conti, et al.
Transplantation|December 10, 2009
Interleukin-17-producing T-helper cells as new potential player mediating graft-versus-host disease in patients undergoing allogeneic stem-cell transplantationErica Dander, Adriana Balduzzi, Greta Zappa, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 31, 2010
Platelet-lysate-expanded mesenchymal stromal cells as a salvage therapy for severe resistant graft-versus-host disease in a pediatric populationGiovanna Lucchini, Martino Introna, Erica Dander, et al.
Current Pharmaceutical Design|January 3, 2013
Mesenchymal stem/stromal cells: a new ''cells as drugs'' paradigm. Efficacy and critical aspects in cell therapyLaura de Girolamo, Enrico Lucarelli, Giulio Alessandri, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 12, 2020
Targeting CD33 in Chemoresistant AML Patient-Derived Xenografts by CAR-CIK Cells Modified with an Improved SB Transposon SystemMaria Caterina Rotiroti, Chiara Buracchi, Silvia Arcangeli, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 18, 2017
Phase II Study of Sequential Infusion of Donor Lymphocyte Infusion and Cytokine-Induced Killer Cells for Patients Relapsed after Allogeneic Hematopoietic Stem Cell TransplantationMartino Introna, Federico Lussana, Alessandra Algarotti, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 11, 2013
Treatment of graft versus host disease with mesenchymal stromal cells: a phase I study on 40 adult and pediatric patientsMartino Introna, Giovanna Lucchini, Erica Dander, et al.
Leukemia & Lymphoma|March 8, 2022
Lenalidomide enhances CD23.CAR T cell therapy in chronic lymphocytic leukemiaSarah Tettamanti, Maria Caterina Rotiroti, Greta Maria Paola Giordano Attianese, et al.
The Journal of Clinical Investigation|August 12, 2020
Sleeping Beauty-engineered CAR T cells achieve antileukemic activity without severe toxicitiesChiara F Magnani, Giuseppe Gaipa, Federico Lussana, et al.
Pageof 6